Covered recipient · General Payments record
GAURANG M PALIKH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,118.18
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $518.71 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $308.89 | 3 |
| Teva Pharmaceuticals USA, Inc. | $89.16 | 2 |
| Lilly USA, LLC | $72.31 | 2 |
| Ipsen Biopharmaceuticals, Inc | $24.62 | 1 |
| ABBVIE INC. | $23.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.73 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105171938 | CMS |
| Ipsen Biopharmaceuticals, Inc | $24.62 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091990187 | CMS |
| JAZZ PHARMACEUTICALS INC. | $102.50 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150232477 | CMS |
| JAZZ PHARMACEUTICALS INC. | $144.35 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150232479 | CMS |
| JAZZ PHARMACEUTICALS INC. | $62.04 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150232481 | CMS |
| Lilly USA, LLC | $22.72 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985720 | CMS |
| Lilly USA, LLC | $49.59 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134996468 | CMS |
| Teva Pharmaceuticals USA, Inc. | $44.16 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151710283 | CMS |
| Teva Pharmaceuticals USA, Inc. | $45.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151710517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.